Lateral flow tests or immunochromatographic assays are conducted using simple devices in order to detect the presence (or absence) of a target analyte in a sample (matrix) without the need for specialized and costly equipment. Lateral flow test kits contains capillary beds such as sintered polymer or porous paper. Capillary beds consist of a sample pad that holds sample fluid and a conjugate pad. The conjugate pad is preloaded with conjugate that is dried form of bioactive substance that enables chemical reaction between target molecule (antigen) and its chemical partner (antibody) while the sample pad holds the sample fluid. Lateral flow tests are designed to deliver diagnostic results without proper laboratory setup. Typically, these tests are used for medical diagnostics either for home testing, point of care testing, or laboratory use. Lateral flow diagnostic tests or immunochromatography tests are diagnostic tests that deliver results in shortest timeframe.
The global lateral flow disease testing market report estimates the market size (Revenue US$ million – 2014 to 2021) for market segmentation based on application (hepatitis, HIV, influenza, malaria, pregnancy, syphilis, others), End Users (Hospitals, Home Testing, Community Testing, Laboratory Testing) and forecasts growth trends (CAGR% – 2017 to 2021).
The global lateral flow disease testing market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global lateral flow disease testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global lateral flow disease testing market and included in this report are Alere, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, EMD Millipore, F. Hoffmann-La Roche Ltd., Qiagen, and Siemens Healthcare.